NEW YORK (GenomeWeb) – Advaita Bioinformatics has received a $125,000 matching grant from the Michigan Emerging Technology Fund, administered through the Michigan Small Business Development Center.
Plymouth, Mich.-based Advaita is using the grant along with another $125,000 in third-party funds to commercialize software for analyzing and interpreting genetic data. These funds give Advaita the requisite resources to bring its product to the research and pharmaceutical market, Sorin Draghici, Advaita's president and CEO, said in a statement.
"We have already seen incredible interest for our software and have established a number of key partnerships that will be announced next month," Draghici said. "These are expected to greatly increase customer use and adoption of our software."
Earlier this year, Advaita received a $1.8 million phase II Small Business Innovation Research grant from the National Institute of General Medical Sciences to develop and implement a new method of identifying disease subtypes and subgroups of patients within disease phenotypes.